THE COST-EFFECTIVENESS OF TREATING HYPERCHOLESTEROLEMIA - WHOM TO TREAT WITH WHAT

被引：0
|
作者：
KINOSIAN, B [1 ]
EISENBERG, JM [1 ]
机构：
[1] UNIV PENN,GEN MED SECT,PHILADELPHIA,PA 19104
来源：
MEDICAL DECISION MAKING | 1986年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：275 / 275
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of a primary care intervention to treat obesity
    Tsai, A. G.
    Wadden, T. A.
    Volger, S.
    Sarwer, D. B.
    Vetter, M.
    Kumanyika, S.
    Berkowitz, R. I.
    Diewald, L. K.
    Perez, J.
    Lavenberg, J.
    Panigrahi, E. R.
    Glick, H. A.
    INTERNATIONAL JOURNAL OF OBESITY, 2013, 37 : S31 - S37
  • [32] What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review
    Ara, R.
    Blake, L.
    Gray, L.
    Hernandez, M.
    Crowther, M.
    Dunkley, A.
    Warren, F.
    Jackson, R.
    Rees, A.
    Stevenson, M.
    Abrams, K.
    Cooper, N.
    Davies, M.
    Khunti, K.
    Sutton, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (05) : 1 - +
  • [33] COST-EFFECTIVENESS CONSIDERATIONS IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH MEDICATIONS
    GOLDMAN, L
    GOLDMAN, PA
    WILLIAMS, LW
    WEINSTEIN, MC
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (10): : D75 - D79
  • [34] Cost-Effectiveness of Pediatric Universal Screening for Familial Hypercholesterolemia in Argentina
    Araujo, Maria B.
    Zerbino, Maria Clara
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 33 : 33 - 41
  • [35] Synthesized economic evidence on the cost-effectiveness of screening familial hypercholesterolemia
    Wang, Mengying
    Jiang, Shan
    Li, Boyang
    Parkinson, Bonny
    Lu, Jiao
    Tan, Kai
    Gu, Yuanyuan
    Li, Shunping
    GLOBAL HEALTH RESEARCH AND POLICY, 2024, 9 (01)
  • [36] To treat or not to treat: Intracranial hemorrhage, immune globulin effectiveness, and cost-effectiveness in pediatric ITP.
    Adams, JR
    Tarantino, MS
    DiLiberti, JH
    Bennett, CL
    BLOOD, 2001, 98 (11) : 863A - 863A
  • [37] What is important in treating osteoarthritis? Whom should we treat and how should we treat them?
    Dieppe, P
    Brandt, KD
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (04) : 687 - +
  • [38] The NICE cost-effectiveness threshold - What it is and what that means
    McCabe, Christopher
    Claxton, Karl
    Culyer, Anthony J.
    PHARMACOECONOMICS, 2008, 26 (09) : 733 - 744
  • [39] What and Whom to Treat With Metaplasia?
    West, A. Brian
    Fisher, Rosemarie
    Kapadia, Cyrus
    Genta, Robert
    Wang, Timothy
    Lauwers, Gregory
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 : S61 - S62
  • [40] What and whom to treat with metaplasia?
    West, AB
    Fisher, R
    Kapadia, C
    Genta, R
    Wang, T
    Lauwers, G
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) : S61 - S62
12345